Print        

Medical Researchers Produce Hepatitis C Medication

Tuesday, July 22, 2008

Iranian researchers from Tehran University of Medical Sciences have produced “pegaferon” which is used to treat hepatitis C for the first time in the country and the second time in the world.

Rasoul Dinarvand, deputy minister of health and medical education for foods and drugs, has been quoted as saying that after many years of studies, researchers from Tehran University of Medical Sciences have produced pegaferon and the new drug has been confirmed by Ministry of Health and Medical Education during the current week and is available on the market.

He added that the drug has been tested on 250 patients at 5 clinics and the results have been very satisfactory, so that, in more than 70 percent of cases, it has been proved successful in treating hepatitis C.

The official noted that this was for the first time in Iran and the second time in the world that Iranian specialists have produced the drug.

“The foreign counterpart of the drug is useful for a single course of treatment and is currently sold for 100 million rials,” he added.

Pegaferon, a recombinant pegylated interferon (PEG-IFN) alpha-2a, has been proven as an effective treatment for chronic hepatitis C.

طراحی و توسعه آگاه‌سیستم